June 17, 2019 – June 20, 2019

Seaport World Trade Center, Boston, MA

Visit us at booth 332!

Presentation by:

Karen DeBalsi, PhD, Senior Study Director, Metabolon, Inc.

Precision Metabolomics™ as a Leading Technology in Biomarker Discovery

June 20, 2019 at 9:15 AM

The metabolome is highly responsive to homeostatic changes induced by genetics, external factors and treatment, which provides an ideal measure to track the connection of these influences to phenotype.  We will discuss how Metabolon’s Precision MetabolomicsTM technology is a powerful tool for biomarker discovery to predict disease and patient response.

More Information